NEW YORK (GenomeWeb News) - ID Business Solutions has inked an agreement to acquire InforSense for an undisclosed sum, IDBS announced today.
The all-cash deal is expected to be completed in July.
IDBS said that the addition of InforSense's product portfolio will expand the firm's large-scale data integration efforts and broaden its life sciences portfolio into the growth areas of biomarker development and personalized medicine. Guildford, UK-based IDBS said that InforSense has developed "state of the art applications to integrate genomics, biomarker and clinical data, that provide a unique offering to researchers in the developing areas of translational and personalised medicine."
"This is a major enabling step towards becoming the number one informatics partner of R&D worldwide," Neil Kipling, CEO and founder of IDBS, said in a statement. "An additional facet of this acquisition is the opportunity to cement a strategic informatics research relationship with Imperial College. The combination of our rigorous software development and powerful new research capabilities creates a groundbreaking new organisation."
Following the deal, InforSense Founder Yi Ke Guo will become chief innovation officer at IDBS.